Coverart for item
The Resource Therapeutic Perspectives in Type-1 Diabetes

Therapeutic Perspectives in Type-1 Diabetes

Label
Therapeutic Perspectives in Type-1 Diabetes
Title
Therapeutic Perspectives in Type-1 Diabetes
Creator
Contributor
Subject
Language
eng
Member of
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Series statement
SpringerBriefs in Applied Sciences and Technology
Therapeutic Perspectives in Type-1 Diabetes
Label
Therapeutic Perspectives in Type-1 Diabetes
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=4441857
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Related Items
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Contents -- Overview -- 1 Introduction to Diabetes and Type 1 Diabetes -- 1.1 Introduction -- 1.1.1 Defining Diabetes -- 1.1.2 Type 1 Diabetes: Epidemiology and Perspectives of a Global Epidemic -- References -- 2 Triggers Causing Type 1 Diabetes -- 2.1 Introduction -- 2.1.1 Genetic Susceptibilty -- 2.1.1.1 Human Leucocyte Antigen (HLA Genes) -- 2.1.1.2 Non-Human Leucocyte Antigen (Non-HLA Genes) -- 2.1.2 Environmental Triggers -- 2.1.2.1 Viruses -- 2.1.2.2 Dietary Factors -- 2.1.2.3 Early Dietary Habits-Cow's Milk and Gluten -- 2.1.2.4 Nitroso Compounds -- 2.1.2.5 Vitamin D -- References -- 3 Predictors and Pathogenesis of Type 1 Diabetes -- 3.1 Key Predictors of Type 1 Diabetes -- 3.1.1 Pathophysiology of Type 1 Diabetes: What Goes Awry? -- 3.1.1.1 T-Cells: A Double Edge Sword -- 3.1.1.2 B-Lymphocytes Producing Diabetes-Associated Autantibodies -- References -- 4 Type 1 Diabetes: Past, Present, and Future Therapies -- 4.1 Introduction -- 4.2 Insulin Replacement -- 4.3 Ý-Cell Replacement: Transplantation Versus Regeneration -- 4.3.1 Islet and Pancreas Transplantation -- 4.3.2 Islet Regeneration -- 4.3.3 Stem Cell-Derived Ý-Cell Replacement -- 4.4 Immune Intervention Strategies -- 4.4.1 Nonantigen-Based Intervention Strategies -- 4.4.1.1 Immunosuppression -- 4.4.1.2 Antibody-Based Immunotherapy -- T-Cell Targeting Antibodies -- Anti-CD3 Antibody (Otelixizumab and Teplizumab) -- Anti-CD25 (Daclizumab) -- Anti-thymocyte Globulin-Thymoglobulin® -- Cytotoxic T-Lymphocyte Antigen 4 Immunoglobulin (CTLA4-Ig) -- B-Cell Targeting Antibody -- Anti-CD20 (Rituximab) -- 4.4.1.3 Cytokine-Based Therapy -- Interleukin 1 (IL-1) -- Interleukin 2 (IL-2) -- Tumor Necrosis Factor-Alpha (TNF-Ü) -- 4.4.2 Antigen-Based Intervention Strategies -- 4.4.2.1 Insulin Vaccine -- 4.4.2.2 Heat Shock Protein 60(Hsp-60)/Diapep277 -- 4.4.2.3 Glutamic Acid Decarboxylase 65 (GAD65)
  • 4.4.3 Cell-Based Therapy -- 4.4.3.1 CD4+CD25+Foxp3 T-Cell -- 4.4.3.2 Dendritic Cells -- 4.5 Combination Therapies in Type 1 Diabetes, the Way Forward? -- 4.6 Lesson Learnt from Animal Models -- 4.7 Perspective of Nanotechnology in Type 1 Diabetes Drug Delivery -- 4.8 Conclusion and Perspectives -- References
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9789811006029&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4384965'}
Extent
1 online resource (87 pages)
Form of item
online
Isbn
9789811006029
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...